When combined with artificial, insulin-​releasing beta cells, this gives rise to a system that can autonomously regulate blood sugar levels

29-Mar-2023

A fuel cell under the skin that converts blood sugar from the body into electrical energy sounds like science fiction. Yet it works perfectly, as an ETH Zurich research team led by Martin Fussenegger, Professor of Biotechnology and Bioengineering, has shown. In type 1 diabetes, the body does not ...

more

Microbiome therapeutics biotech mbiomics raises EUR 13 million in first closing of Series A round

28-Mar-2023

mbiomics GmbH, a pioneering microbiome biotech company developing the first generation of effective microbiome-based therapeutics announced the first closing of EUR13 million (US$ 15 million) of a series A financing round led by MIG Capital. High-Tech Gründerfonds and Bayern Kapital joined the ...

more

Start-up aims to revolutionize treatment of severe diseases

23-Mar-2023

Seamless Therapeutics, a Dresden based start-up of the Technische Universität Dresden, announced a $12.5 million (€11.8M) seed financing round which will accelerate further development of its designer recombinases, a novel gene editing platform to transform the treatment of severe diseases. ...

more

New Findings on the Prevention of Retrovirus Infections

22-Mar-2023

Intensive research is being carried out to enable the transplantation of organs from specially bred pigs to humans. However, the pig genome contains the genomes of various endogenous retroviruses (PERV-A, B and C) that could potentially cause infectious diseases. A research team at the ...

more

BioNTech and OncoC4 announce strategic collaboration

22-Mar-2023

BioNTech SE and OncoC4, Inc., a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel biologicals for cancer treatment, announced that they have entered into an exclusive worldwide license and collaboration agreement to develop and commercialize OncoC4’s ...

more

2022 brought record investment sums for research-based start-ups managed by Max Planck Innovation

21-Mar-2023

A successful business year for Max Planck Innovation includes increasing investment sums for the start-ups managed. Especially life sciences start-ups with a high degree of maturity provided a record sum of 225 million euros. Companies in the Max Planck Innovation investment portfolio raised over ...

more

21-Mar-2023

lino Biotech, a biosensor company and the world’s only provider of Focal Molography®, announced it has been acquired by Miltenyi Biotec, a global biotech company based in Germany, on February 22, 2023. Since its founding in 2020, lino Biotech has made significant advances in developing new ...

more

20-Mar-2023

INTEGRA Biosciences announced that it has acquired Miroculus, a biotechnology specialist focused on developing hands-off automation solutions for next generation sequencing (NGS) protocols. This will allow INTEGRA to expand its product range for library preparation, offering significant time ...

more

BluCon Biotech's technology has the potential to be a disruptive game changer in the world's plastics market

16-Mar-2023

BluCon Biotech, a German biotech company, and LG Chem,a Korean chemical company, have entered into an investment agreement to scale up and commercialize BluCon Biotech’s proprietary technology to supplement LG Chem´s bio-economy portfolio BluCon Biotech’s technology has the potential to be a ...

more

15-Mar-2023

Chromologics, the Danish biotech company specializing in production of innovative natural food colors, today announced the successful closure of an extended seed round. The company raised an additional EUR 7.1 million in equity from its existing investors plus two new investors. "We are thrilled ...

more